Search Results

MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, and maker of AGM100, will sponsor this year’s annual UCSD John B. West Distinguished Lecture event featuring Nobel Laureate Gregg L. Semenza, MD, PhD.

In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology thought leaders discussed a new non-invasive measurement; Oxygen Deficit, obtained from the MediPines AGM100, which demonstrated 99% clinical accuracy for supplemental oxygen therapy decisions.

Orange County, California based MediPines Corporation has announced the addition of Gary C. Sieck, PhD; George M. Zlupko, MD, FCCP; and Aidan Raney, MD, FACC to its medical and scientific advisory board.

Orange County, California based MediPines Corporation, a global market leader in the development of gas exchange monitoring technology, has announced full national distribution throughout the United States for its unique AGM100 device, the world’s first FDA-cleared, non-invasive pulmonary gas exchange analyzer system.

MediPines is pleased to announce that their AGM100 device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence Awards.

The World Health Organization has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology in their 2021 compendium, “WHO compendium of innovative health technologies for low-resource settings”.

We are pleased to announce that MediPines AGM100™, a non-invasive pulmonary gas exchange analyzer, was selected as a finalist in the 2021 Medical Design Excellence Awards.

MediPines Corporation, in keeping with their mission of advancing respiratory medicine, has released a statement of guidance on the use of the MediPines Gas Exchange Monitor in the monitoring of patients that have symptoms of suspected COVID-19 or other respiratory infections.

An increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and diagnosis of pulmonary embolism (PE) in patients.

In an effort to support healthcare providers facing massive healthcare burdens due to the current respiratory challenges caused by COVID-19, MediPines has released a timely scientific discussion on oxygen saturation versus pulmonary gas exchange as a respiratory monitoring imperative for COVID-19 patients.